Skip to content

Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot Study

Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04229316
Enrollment
24
Registered
2020-01-18
Start date
2018-04-12
Completion date
2024-05-31
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

stabilization, facet arthritis, spondylolisthesis, stenosis

Brief summary

ZygoFix has developed a system consisting of zLOCK Facet Fusion System. The zLOCK Facet Fusion System is intended for single level stabilization of a spinal motion segment to promote bonny fusion of the joint. The system is designed for percutaneous deployment. The zLOCK implant is designed to be deployed in the facet joint thereby utilizing the body's natural mechanical structure without adding an external scaffold (see figure below). The zLOCK implant is inserted into the facet joint space while it adapts to the joint's changing geometry. Stabilization is achieved by firm grip of each joint bone and resisting to any relative motion. The zLOCK implant is placed percutaneously and requires only one incision per side, thereby reducing the invasiveness, procedure duration and shorten the recovery period. This pilot study was designed in order to assess the safety and effectiveness of the zLOCK system.

Interventions

zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains

Sponsors

ZygoFix
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patient is scheduled for spine surgery with at least one of the following: When used in adjunct to an intervertebral front cage: * Degenerative Spondylolisthesis up to grade 2 * Mild to Moderate Degenerative disc disease (DDD) * Degeneration of the facets - following validating the pain source by facet injection. When used stand-alone: * Degenerative Spondylolisthesis grade 1-2 * Moderate to severe Stenosis with listhesis * Moderate to severe stenosis without listhesis (in cases that the investigator determines stabilization is required). * Degeneration of the facets- following validating the pain source by facet injection. 2. Claudication due to moderate to severe stenosis (central/ foraminal) as verified by imaging. 3. 18\< Age \< 75 4. Weight \< 100Kg 5. Signed informed consent form 6. At least 3 months of unsuccessful conventional treatments

Exclusion criteria

1. Fusion procedure performed or required in more than one inter-vertebrae space. 2. Active systemic infection or infection localized to the site of the proposed implantation are contraindications to implantation. 3. Osteoporosis 4. Absence of posterior spinal elements including the pedicle, pars interarticularis, facet joints, spinous process and the majority of the lamina which make it unstable or not possible to place. 5. Any entity or conditions that totally preclude the possibility of fusion, i.e., cancer, kidney dialysis, or osteopenia, are relative contraindications. 6. Obesity (BMI ≥30) 7. Foreign body sensitivity 8. Alcoholism, or drug abuse 9. Subject with a cardiac pacemaker or other implanted electro medical device 10. Subject with known condition of drug abuse and/or alcoholism 11. Women who are either pregnant or nursing at the time of screening (to be verified by test in case of woman of child-bearing potential that do not practice medically acceptable methods of contraception) 12. Concurrent participation in another clinical trial using any investigational drug or device. 13. Mental disorders.

Design outcomes

Primary

MeasureTime frameDescription
Safety assessment - no device related reoperation3 monthsThe safety of the zLOCK Facet Implant System will be established based on the absence of device related reoperations.

Secondary

MeasureTime frameDescription
Efficacy assessment - achieving facet fusion 12 months post procedure12 monthsThe efficacy of using the zLOCK System will be determined by achieving facet fusion 12 months post procedure. Patient is defined success if facet fusion is achieved at 12 months post procedure.

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026